Cymer Reports Fourth Quarter and 2011 Operating Results
SAN DIEGO, Feb. 2, 2012 /PRNewswire/ -- Cymer, Inc. (Nasdaq: CYMI), the world's leading supplier of light sources used by chipmakers to manufacture advanced semiconductor devices, today announced operating results for the fourth quarter and year ended December 31, 2011.
(Logo: http://photos.prnewswire.com/prnh/20090406/LA94420LOGO)
For the fourth quarter of 2011:
-- net income totaled $12.5 million, equal to $0.40 per share (diluted),
compared to net income of $32.9 million, equal to $1.08 per share
(diluted) in the fourth quarter of 2010 and net income of $11.3 million,
equal to $0.36 per share (diluted), in the third quarter of 2011.
-- revenue totaled $152.9 million compared to revenue of $146.9 million in
the fourth quarter of 2010, and revenue of $128.7 million in the third
quarter of 2011.
For the year ended December 31, 2011:
-- net income totaled $80.2 million equal to $2.58 per share (diluted),
compared to net income of $91.0 million, equal to $3.02 per share
(diluted) for the year ended December 31, 2010.
-- revenue totaled $594.2 million compared to revenue of $534.2 million in
the prior year.
Commenting on results, Bob Akins, Cymer's chief executive officer, said, "In 2011 we achieved record company revenue and delivered targeted margins while significantly increasing our investment in extreme ultraviolet (EUV) source technology. In the fourth quarter, deep ultraviolet (DUV) pulses at chipmakers remained high. We also began delivering product enhancements increasing customer realized value for OnPulse covered light sources. DUV light source shipments increased from third quarter levels and we were pleased to have received customer acceptance on three of the six 3100 EUV sources we have shipped to date. During the fourth quarter we also completed installation of our first TCZ Gen 5 system at a leading display manufacturer."
In the fourth quarter of 2011, the company shipped 32 light sources, of which 18 were KrF and 14 were ArF immersion, and the company installed 33 DUV light sources at chipmaker locations. Gross profit was $76.4 million for the fourth quarter of 2011, yielding a 50 percent gross margin. Total operating expenses, which include research and development and selling and administrative expenses, were $54.8 million. Total operating income was $21.6 million or 14.1 percent of revenue. The 2011 effective tax rate was 26 percent, resulting in a fourth quarter effective tax rate of 42 percent. This rate was higher than originally planned due to lower than anticipated annual R&D tax credits and higher than forecasted fourth quarter pre-tax income.
DUV and Installed Base Products (IBP) bookings for the fourth quarter of 2011 totaled $125 million, resulting in a book-to-bill ratio of 0.96. Forty-two percent of the DUV bookings were ArF immersion and 58 percent were KrF. The company ended the quarter with a DUV backlog of approximately $48 million.
For the full year 2011, the company shipped 154 DUV light sources, of which 88 were ArF immersion, 61 were KrF, and 5 were ArF dry. The company reported gross profit of $305.1 million for the full year 2011, yielding a 51.4 percent gross margin. Total operating expenses for the year of $197.6 million includes research and development, selling and administrative expenses. Total operating income was $107.6 million or 18.1 percent of revenue.
As of December 31, 2011, cash and investments totaled approximately $324 million, an increase of approximately $107 million from December 31, 2010.
Company Outlook
Commenting on the outlook for the first quarter of 2012, Akins stated, "We expect Installed Base Products revenue to remain at or above the prior quarter level led by installed base growth, increased ArF pulses and light source product enhancements. We anticipate shipping a similar number of DUV ArF Immersion light sources, as compared to last quarter, but a lower number of KrF. We also anticipate recognizing revenue on our fourth 3100 EUV source and our third TCZ system. We will continue to invest in EUV development resources, manufacturing capacity, and field support. We view 2012 as a pivotal year for advancing power and performance for 3100 fielded sources and 3300 source demand."
Based on information available at this time, Cymer is providing the following guidance for the first quarter of 2012:
-- Revenue to be approximately $138 million.
-- Gross margin to be approximately 48 to 49 percent.
-- R&D expenses to be approximately $39 to $41 million dollars.
-- SG&A expenses to be approximately $16.5 million.
-- The effective tax rate to be approximately 32 percent.
Cymer's management will hold a conference call at 2:00 pm (PDT) today, February 2, 2012, to discuss fourth quarter and 2011 operating results and first quarter 2012 guidance. This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company's Web site at www.cymer.com.
Forward Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to statements regarding the development and performance of the company's EUV source technology, the company's development of and manufacturing capability for its silicon crystallization tool for the display industry, expectations for DUV pulses and growth in Installed Base Products revenue, and the statements under the caption "Company Outlook" above. These statements are predictions based on current information and expectations and involve a number of risks and uncertainties. In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance. Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: the risk that the company's EUV 3100 sources, which are still under development and not capable of supporting the commercial production of integrated circuits, may not meet customer specifications or may have reliability or performance problems; the risk that commercial EUV systems may not be introduced by the company on time, or at all; the risk that a competitor's EUV or other source may be selected over the company's EUV source; the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; cyclicality in the market for semiconductor manufacturing equipment; the timing of customer orders, shipments and acceptances; delays or cancellations by customers of their orders; the performance and market acceptance of the company's new products or technologies; new and enhanced product offerings by competitors; the company's ability to meet its production and product development schedules; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company's customers; the company's ability to secure adequate supplies of critical components for its advanced products; the company's ability to manage its expense levels and unanticipated expenses; the company's ability to achieve its forecasted gross margin which includes its ability to absorb manufacturing costs; the company's ability to align its cost structure with forecasted business levels; the company's ability to manage its foreign currency exposure; the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions. For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission (SEC). You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
About Cymer
Cymer, Inc. (Nasdaq: CYMI) is the market leader in developing light sources, used by chipmakers worldwide to pattern advanced semiconductor chips, and is pioneering a new silicon crystallization tool for the display industry. Cymer's light sources have been widely adopted by the world's top chipmakers and the company's installed base comprises approximately 3,750 systems. Continuing its legacy of leadership, Cymer is currently pioneering the industry's transition to EUV lithography, the next viable step on the technology roadmap for the creation of smaller, faster chips. The company is headquartered in San Diego, Calif., and supports its customers from numerous offices around the globe. Cymer maintains a Web site to which it regularly posts press releases, SEC filings, and additional information about Cymer. Interested persons can also subscribe to automated e-mail alerts or RSS feeds. Please visit www.cymer.com.
Cymer and all other Cymer product or service names used herein are either registered trademarks or trademarks of Cymer, Inc. Any other marks mentioned herein are the property of their respective holders.
CYMER, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(in thousands, except per share data)
Three Months
Ended Years Ended
December 31, December 31,
------------ ------------
2011 2010 2011 2010
---- ---- ---- ----
Revenue $152,880 $146,854 $594,212 $534,209
Cost of revenue 76,504 68,859 289,076 261,442
------ ------ ------- -------
Gross profit 76,376 77,995 305,136 272,767
------ ------ ------- -------
Operating expenses:
Research and
development 37,164 25,043 130,638 89,193
Sales and marketing 6,900 5,464 25,126 22,656
General and
administrative 10,708 10,352 41,793 39,802
------ ------ ------ ------
Total operating
expenses 54,772 40,859 197,557 151,651
------ ------ ------- -------
Operating income 21,604 37,136 107,579 121,116
------ ------ ------- -------
Other income
(expense):
Foreign currency
exchange (loss)
gain (133) 11 742 (6)
Interest income 381 132 848 524
Interest expense (220) (189) (741) (605)
Other income 6 9 6 55
Total other income
(expense) 34 (37) 855 (32)
--- --- --- ---
Income before income
taxes 21,638 37,099 108,434 121,084
Income tax expense 9,167 4,236 28,193 30,271
----- ----- ------ ------
Net income $12,471 $32,863 $80,241 $90,813
------- ------- ------- -------
Net loss
attributable to
noncontrolling
interest in
subsidiary - - - 148
--- --- --- ---
Net income
attributable to
Cymer, Inc. $12,471 $32,863 $80,241 $90,961
======= ======= ======= =======
Earnings per share:
Basic $0.41 $1.11 $2.63 $3.05
===== ===== ===== =====
Diluted $0.40 $1.08 $2.58 $3.02
===== ===== ===== =====
Weighted average
shares outstanding:
Basic 30,588 29,710 30,469 29,777
====== ====== ====== ======
Diluted 31,289 30,351 31,101 30,124
====== ====== ====== ======
CYMER, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in thousands)
December 31,
------------
2011 2010
---- ----
ASSETS
Current assets:
Cash and cash equivalents $125,027 $154,312
Restricted cash 5,903 -
Short-term investments 124,712 54,964
Accounts receivable, net 123,970 127,747
Inventories 221,740 213,002
Deferred income taxes 26,963 11,961
Other current assets 35,601 55,027
------ ------
Total current assets 663,916 617,013
Long-term investments 73,811 7,506
Property, plant and equipment, net 119,015 104,705
Deferred income taxes 34,591 35,690
Goodwill 16,792 8,833
Intangible assets, net 9,928 7,645
Other assets 9,691 5,939
Total assets $927,744 $787,331
======== ========
LIABILITIES
Current liabilities:
Accounts payable $38,876 $27,731
Deferred revenue 56,546 30,593
Deferred income taxes 171 -
Other current liabilities 49,619 68,121
------ ------
Total current liabilities 145,212 126,445
Deferred revenue 5,871 690
Deferred income taxes 1,463 21
Other liabilities 27,255 21,920
Total liabilities 179,801 149,076
======= =======
EQUITY
Cymer, Inc. stockholders' equity:
Preferred stock - -
Common stock 44 43
Additional paid-in capital 658,755 620,272
Treasury stock (492,890) (492,890)
Accumulated other comprehensive loss (11,918) (2,881)
Retained earnings 593,952 513,711
------- -------
Total equity 747,943 638,255
Total liabilities and equity $927,744 $787,331
======== ========
CYMER, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
Years Ended
December 31,
------------
2011 2010
---- ----
Operating activities:
Net income $80,241 $90,813
Adjustments to reconcile net income to
net cash provided by
operating activities:
Depreciation, amortization and accretion 20,291 19,223
Stock-based compensation 18,118 10,603
Bad debt recoveries (306) (843)
Excess tax benefits from stock option
exercises (4,017) (2,087)
Provision for deferred income taxes (8,929) 12,755
Loss on disposal or impairment of
property, plant and equipment 127 609
Change in assets and liabilities:
Restricted cash (5,903) 1,235
Accounts receivable 3,885 (48,659)
Accounts receivable, related party - 732
Inventories (14,678) (30,698)
Other assets 14,894 (27,947)
Accounts payable 8,857 7,976
Accounts payable, related party - (9,284)
Deferred revenue 28,806 8,665
Other liabilities (24,927) 21,395
------- ------
Net cash provided by operating activities 116,459 54,488
------- ------
Investing activities:
Acquisition of property, plant and
equipment (25,250) (15,810)
Cash paid for acquisition of eDiag, net
of cash acquired (3,785) -
Purchases of investments (305,172) (100,056)
Proceeds from sold or matured investments 167,986 105,211
------- -------
Net cash used in investing activities (166,221) (10,655)
-------- -------
Financing activities:
Proceeds from issuance of common stock 16,320 9,446
Purchase of noncontrolling interest - (2,186)
Excess tax benefits from stock option
exercises 4,017 2,087
Repurchase of common stock into treasury - (19,310)
Payments under capital lease obligations (155) -
---- ---
Net cash provided by (used in) financing
activities 20,182 (9,963)
------ ------
Effect of exchange rate changes on cash
and cash equivalents 295 2,061
--- -----
Net (decrease) increase in cash and cash
equivalents (29,285) 35,931
Cash and cash equivalents at beginning of
the year 154,312 118,381
------- -------
Cash and cash equivalents at end of the
year $125,027 $154,312
======== ========
Supplemental disclosure of cash flow
information:
Interest paid $234 $405
==== ====
Income taxes paid $35,070 $42,295
======= =======
Supplemental disclosure of non-cash
operating, investing and financing
activities:
Net increase (decrease) in acquisition of
property and equipment included in
accounts payable $1,443 $(1,774)
====== =======
Net decrease (increase) in in-transit
proceeds from issuance of common stock $41 $(11)
=== ====
Property and equipment acquired under
capital lease obligations $738 $136
==== ====
Future install payments for acquisition
of eDiag $8,412 $-
====== ===
SOURCE Cymer, Inc.